Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHILPA MEDICARE Gains 10%; BSE HEALTHCARE Index Up 0.5%
Fri, 5 Jul 10:2

SHILPA MEDICARE Gains 10%; BSE HEALTHCARE Index Up 0.5%Image source: Ivcandy/www.istockphoto.com

SHILPA MEDICARE share price has zoomed 10% and is presently trading at Rs 637.5.

Meanwhile, the BSE HEALTHCARE index is at 38,055.6 (up 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are Glenmark Pharma (up 2.5%) and FORTIS HEALTHCARE (up 2.3%).

ASTRAZENECA PHARMA (down 1.8%) and METROPOLIS HEALTHCARE (down 1.8%) are among the top losers today.

Over the last one year, SHILPA MEDICARE has moved up from Rs 288.5 to Rs 637.5, registering a gain of Rs 349.1 (up 121.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 38,055.6, registering a gain of 48.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 101.3%), Cadila Healthcare (up 98.6%) and Lupin (up 97.8%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,532.1 (down 0.6%).

The top losers among the BSE Sensex today are HDFC Bank (down 4.1%) and M&M (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 24,187.4 (down 0.5%). HDFC Bank and M&M are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 79,532.1, registering a gain of 14,327.1 points (up 22.0%).

SHILPA MEDICARE Financial Update...

SHILPA MEDICARE net profit grew 459.7% YoY to Rs 246 million for the quarter ended March 2024, compared to a loss of Rs 69 million a year ago. Net sales rose 10.7% to Rs 2,917 million during the period as against Rs 2,636 million in January-March 2023.

For the year ended March 2023, SHILPA MEDICARE reported 151.0% decrease in net profit to Rs -309 million compared to net profit of Rs 606 million during FY22. Revenue of the company fell 8.3% to Rs 10,501 million during FY23.

The current Price to earnings ratio of SHILPA MEDICARE, based on rolling 12 month earnings, stands at 169.7.


Equitymaster requests your view! Post a comment on "SHILPA MEDICARE Gains 10%; BSE HEALTHCARE Index Up 0.5%". Click here!